These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1988080

  • 1. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M, Komeshima N, Naito M, Isoe T, Otake N, Tsuruo T.
    Cancer Res; 1991 Jan 01; 51(1):157-61. PubMed ID: 1988080
    [Abstract] [Full Text] [Related]

  • 2. 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks.
    Horichi N, Tapiero H, Sugimoto Y, Bungo M, Nishiyama M, Fourcade A, Lampidis TJ, Kasahara K, Sasaki Y, Takahashi T.
    Cancer Res; 1990 Aug 01; 50(15):4698-701. PubMed ID: 2164445
    [Abstract] [Full Text] [Related]

  • 3. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
    Watanabe M, Komeshima N, Nakajima S, Tsuruo T.
    Cancer Res; 1988 Dec 01; 48(23):6653-7. PubMed ID: 3180075
    [Abstract] [Full Text] [Related]

  • 4. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N.
    Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873
    [Abstract] [Full Text] [Related]

  • 5. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1984 Mar 01; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [Abstract] [Full Text] [Related]

  • 6. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.
    Naito M, Tsuruo T.
    Cancer Res; 1989 Mar 15; 49(6):1452-5. PubMed ID: 2924298
    [Abstract] [Full Text] [Related]

  • 7. Establishment of a human leukemia subline resistant to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and showing non-P-glycoprotein-mediated multi-drug resistance.
    Takeda Y, Nishio K, Sugimoto Y, Kasahara K, Kubo S, Fujiwara Y, Niitani H, Saijo N.
    Int J Cancer; 1991 Jul 30; 48(6):931-7. PubMed ID: 1677641
    [Abstract] [Full Text] [Related]

  • 8. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K, Tsuruo T.
    Cancer Res; 1989 Sep 15; 49(18):5002-6. PubMed ID: 2569930
    [Abstract] [Full Text] [Related]

  • 9. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y.
    Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778
    [Abstract] [Full Text] [Related]

  • 10. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H, Nguyen-Ba G, Lampidis TJ.
    Pathol Biol (Paris); 1994 Apr 15; 42(4):328-37. PubMed ID: 7808786
    [Abstract] [Full Text] [Related]

  • 11. An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
    Park SJ, Kaye AH, Hill JS.
    J Clin Neurosci; 2000 Jan 15; 7(1):42-7. PubMed ID: 10847650
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
    Yamamoto S, Hui PZ, Fukuda Y, Tatsumi K, Mino M.
    Biochem Int; 1989 Jun 15; 18(6):1077-83. PubMed ID: 2751676
    [Abstract] [Full Text] [Related]

  • 13. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T.
    Prog Clin Biol Res; 1986 Jun 15; 223():203-16. PubMed ID: 3468516
    [Abstract] [Full Text] [Related]

  • 14. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Dong J, Naito M, Tatsuta T, Seimiya H, Johdo O, Tsuruo T.
    Oncol Res; 1995 Jun 15; 7(5):245-52. PubMed ID: 8534930
    [Abstract] [Full Text] [Related]

  • 15. [Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro].
    Kabuto M, Kubota T, Kobayashi H, Nakagawa T, Kitai R, Uno H, Kodera T.
    No To Shinkei; 1995 Oct 15; 47(10):969-73. PubMed ID: 7577142
    [Abstract] [Full Text] [Related]

  • 16. Cross-resistance of human multidrug-resistant cells to mitomycin C.
    Yusa K, Sato W, Yamazaki A, Tsukahara S, Tsuruo T.
    Anticancer Res; 1991 Oct 15; 11(3):1301-4. PubMed ID: 1909515
    [Abstract] [Full Text] [Related]

  • 17. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
    Hu XF, Slater A, Rischin D, Kantharidis P, Parkin JD, Zalcberg J.
    Br J Cancer; 1999 Feb 15; 79(5-6):831-7. PubMed ID: 10070877
    [Abstract] [Full Text] [Related]

  • 18. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Oct 15; 44(10):4303-7. PubMed ID: 6467192
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.
    Hong WS, Jung HY, Yang SK, Kim HR, Min YI.
    Anticancer Res; 1997 Oct 15; 17(5A):3613-6. PubMed ID: 9413212
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
    Tsuruo T, Iida-Saito H, Kawabata H, Oh-hara T, Hamada H, Utakoji T.
    Jpn J Cancer Res; 1986 Jul 15; 77(7):682-92. PubMed ID: 3091555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.